FDA to discuss liprotamase

FDA's Gastrointestinal Drugs Advisory Committee will meet on Jan. 12 to discuss an NDA from Eli Lilly and Co. (NYSE:LLY) for Solpura liprotamase capsules to treat exocrine pancreatic insufficiency (EP...